ArticleInternational journal of molecular sciences2026
Selective PPARα Modulator Pemafibrate Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Regulation of Leptin Signaling and Remodeling of Gut Microbiota.
Koji Yamamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.